Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.620
-0.210 (-4.35%)
Nov 17, 2026, 4:00 PM EST - Market closed

Evolent Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,3431,8762,5551,9641,352907.96
Revenue Growth
14.06%-26.56%30.09%45.26%48.91%-1.80%
Cost of Revenue
1,9931,4762,1871,5031,035657.55
Gross Profit
350.28399.88367.35460.47316.58250.41
Selling, General & Admin
271.17288.47246.64322.87269.27207.78
Operating Expenses
380.82404.32343.41446.29336.46267.82
Operating Income
-30.53-4.4423.9414.18-19.88-17.41
Interest Expense
-69.73-57.47-24.72-54.21-15.57-25.43
Interest & Investment Income
3.564.195.545.261.370.41
Earnings From Equity Investments
0.030.37-3.441.294.5713.18
Other Non Operating Income (Expenses)
0-53.10.07-62.53-45.89-0.15
EBT Excluding Unusual Items
-96.67-110.451.39-96-75.41-29.4
Merger & Restructuring Charges
-5.82-5.25-13.53-35.24--11.72
Impairment of Goodwill
-398-398----
Gain (Loss) on Sale of Assets
14.8714.87--8.11-45.94
Asset Writedown
---24.19-24.07--
Other Unusual Items
-19-35.8-26.71-38.9913.33-34.62
Pretax Income
-504.63-534.64-63.04-202.41-62.08-29.8
Income Tax Expense
3.07-0.13-1.41-89.37-43.380.48
Earnings From Continuing Operations
-507.69-534.51-61.62-113.04-18.7-30.28
Earnings From Discontinued Operations
-----0.46-7.32
Net Income to Company
-507.69-534.51-61.62-113.04-19.16-37.6
Net Income
-507.69-534.51-61.62-113.04-19.16-37.6
Preferred Dividends & Other Adjustments
-44.8931.8329.22--
Net Income to Common
-507.69-579.4-93.45-142.26-19.16-37.6
Net Income Growth
------
Shares Outstanding (Basic)
1121141151119486
Shares Outstanding (Diluted)
1121141151119486
Shares Change
-2.43%-0.41%3.08%18.73%8.87%1.34%
EPS (Basic)
-4.52-5.07-0.81-1.28-0.20-0.44
EPS (Diluted)
-4.52-5.07-0.81-1.28-0.20-0.44
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
35.26-52.69-14.35113.84-59.0811.25
Free Cash Flow Per Share
0.31-0.46-0.131.02-0.630.13
Gross Margin
14.95%21.31%14.38%23.45%23.42%27.58%
Operating Margin
-1.30%-0.24%0.94%0.72%-1.47%-1.92%
Profit Margin
-21.67%-30.88%-3.66%-7.24%-1.42%-4.14%
Free Cash Flow Margin
1.50%-2.81%-0.56%5.80%-4.37%1.24%
EBITDA
56.0288.2295.11110.920.3216.13
EBITDA Margin
2.39%4.70%3.72%5.65%1.50%1.78%
D&A For EBITDA
86.5592.6571.1796.7240.233.54
EBIT
-30.53-4.4423.9414.18-19.88-17.41
EBIT Margin
-1.30%-0.24%0.94%0.72%-1.47%-1.92%
SEC Filings: 10-K · 10-Q